Sino-High (China) Co. Ltd. (301076.SZ) stock: key figures, P/E, revenue and dividend
Materials · Commodity Chemicals · China · ISIN CNE100004RX3
Sino-High (China) Co. Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 419.46 m CNY | 443.80 m CNY |
| Gross profit | 98.53 m CNY | 118.25 m CNY |
| Operating income | 45.76 m CNY | 61.92 m CNY |
| EBIT | 63.43 m CNY | 61.92 m CNY |
| Net income | 55.97 m CNY | 66.61 m CNY |
| Diluted EPS – continuing operations | 0.25 CNY | 0.29 CNY |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Sino-High (China) Co. Ltd.
Sino-High (China) Co., Ltd. engages in the research and development, production, and sale of aromatic ketone products in China and internationally. It offers acetophenone and benzophenone derivatives, and others. Its products are used in medical and agricultural intermediates, photo initiators, plastic monomer, and cosmetic raw material applications. The company was incorporated in 2008 and is headquartered in Nanjing, China.
More stocks
- ARDELYX, INC. (ARDX)
- Surge Energy Inc (Alberta) (SGY.TO)
- WELL Health Technologies Corp (WELL.TO)
- Lectra SA (LSS.PA)
- Suzhou Shihua New Material Technology Co Ltd (688093.SS)
- Koppers Holdings Inc. (KOP)
- Shenzhen Sunnypol Optoelectronics Co Ltd (002876.SZ)
- Jiangxi Sanxin Medtec Co Ltd (300453.SZ)
- LSB INDUSTRIES, INC. (LXU)
- Jintuo Technology Co Ltd (603211.SS)
- Frontier Biopharmaceuticals (Nanjing) Co. Ltd. A (688221.SS)
- Viridien SA (VIRI.PA)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.